Literature DB >> 15182607

Transport and centralization of acute coronary syndrome care.

James L Orford1, Peter B Berger.   

Abstract

Primary percutaneous coronary intervention (PCI) is the optimal treatment for patients presenting with ST-elevation myocardial infarction (STEMI). But PCI facilities are not widely available, and the majority of patients who receive reperfusion therapy are treated with thrombolytic therapy. However, with significant improvements in the procedural success of PCI, there has been a concomitant reduction in the need for emergency bypass surgery and there is evidence to support primary PCI without on-site cardiac surgical facilities. Others have proposed immediate transfer to a suitable hospital for immediate primary PCI. An alternative treatment strategy is facilitated PCI, which might combine the early benefits of thrombolysis with the higher patency rates and superior clinical outcomes of primary PCI, although this remains unproven. Finally, rescue PCI remains a reasonable treatment option for patients with failed thrombolysis, but there is insufficient evidence to support this option as a preferred treatment strategy for patients with STEMI.

Entities:  

Mesh:

Year:  2004        PMID: 15182607     DOI: 10.1007/s11886-004-0079-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  56 in total

1.  Evolving strategies in the treatment of acute myocardial infarction in the community hospital setting.

Authors:  Raymond G McKay
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

2.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.

Authors:  J G Canto; N R Every; D J Magid; W J Rogers; J A Malmgren; P D Frederick; W J French; A J Tiefenbrunn; V K Misra; C I Kiefe; H V Barron
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

3.  Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.

Authors:  Robert P Giugliano; Matthew T Roe; Robert A Harrington; C Michael Gibson; Uwe Zeymer; Frans Van de Werf; Kenneth W Baran; Hans Peter Hobbach; Lynn H Woodlief; Karen L Hannan; Sally Greenberg; Joanne Miller; Michael M Kitt; John Strony; Carolyn H McCabe; Eugene Braunwald; Robert M Califf
Journal:  J Am Coll Cardiol       Date:  2003-04-16       Impact factor: 24.094

4.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

5.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

Authors:  T J Ryan; E M Antman; N H Brooks; R M Califf; L D Hillis; L F Hiratzka; E Rapaport; B Riegel; R O Russell; E E Smith; W D Weaver; R J Gibbons; J S Alpert; K A Eagle; T J Gardner; A Garson; G Gregoratos; T J Ryan; S C Smith
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

6.  Low-risk percutaneous coronary interventions without on-site cardiac surgery: two years' observational experience and follow-up.

Authors:  Henry H Ting; Kirk N Garratt; Mandeep Singh; Michael A Kjelsberg; Farris K Timimi; Kevin T Cragun; Robert J Houlihan; Katherine L Boutchee; Christopher H Crocker; Jack T Cusma; Douglas L Wood; David R Holmes
Journal:  Am Heart J       Date:  2003-02       Impact factor: 4.749

7.  Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

Authors:  W D Weaver; M Cerqueira; A P Hallstrom; P E Litwin; J S Martin; P J Kudenchuk; M Eisenberg
Journal:  JAMA       Date:  1993-09-08       Impact factor: 56.272

8.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

Authors:  P Widimský; T Budesínský; D Vorác; L Groch; M Zelízko; M Aschermann; M Branny; J St'ásek; P Formánek
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

9.  A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction.

Authors:  W W O'Neill; R Weintraub; C L Grines; T B Meany; B R Brodie; H Z Friedman; R G Ramos; V Gangadharan; R N Levin; N Choksi
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

Review 10.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.